MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jaci.2011.12.1002

Медицинская библиотека · The Journal of allergy and clinical immunology · 2012

Inhibition of angiogenesis by IL-32: possible role in asthma.

Meyer Norbert, Christoph Janine, Makrinioti Heidi, Indermitte Philippe, Rhyner Claudio, Soyka Michael, Eiwegger Thomas, Chalubinski Maciej, Wanke Kerstin, Fujita Hiroyuki, Wawrzyniak Paulina, Bürgler Simone, Zhang Sherrie, Akdis Mübeccel, Menz Günter, Akdis Cezmi

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

IL-32 is a proinflammatory cytokine involved in various chronic inflammatory diseases. Chronic airway inflammation in asthmatic patients results in structural airway changes, including angiogenesis. Vascular endothelial growth factor (VEGF) is a key inducer of angiogenesis in the airways of asthmatic patients.

OBJECTIVE

The aim of the study was to investigate the expression and function of IL-32 in patients with angiogenesis and asthma.

METHODS

The expression and regulation of IL-32 in normal human bronchial epithelial (NHBE) cells was analyzed by using RT-PCR, ELISA, Western blotting, immunofluorescent staining, and flow cytometry. After knockdown of IL-32 in NHBE cells by small interfering RNA (siRNA) transfections, VEGF secretion was quantified by means of ELISA. New blood vessel formation was determined with human umbilical vein endothelial cells by culturing with supernatants from IL-32 siRNA-transfected NHBE cells. IL-32 was determined in serum and induced sputum samples of asthmatic patients and healthy control subjects by means of ELISA.

RESULTS

IL-32 is expressed in NHBE cells on stimulation with IFN-γ, TNF-α, T(H)1 cells, and rhinovirus. Inhibition of IL-32 expression resulted in significantly increased secretion of the proangiogenic factors VEGF and platelet-derived growth factor by NHBE cells. Human umbilical vein endothelial cells cultured in supernatants from IL-32 siRNA-transfected NHBE cells showed enhanced in vitro angiogenesis. IL-32 is detectable in induced sputum from asthmatic patients. IL-32 serum levels were significantly higher in asthmatic patients compared with those seen in healthy control subjects and correlated with response to asthma treatment.

CONCLUSION

IL-32 is induced by IFN-γ, TNF-α, T(H)1 cells, and rhinovirus in bronchial epithelial cells. It inhibits angiogenesis, and its serum levels are associated with a good treatment response in asthmatic patients.

Для цитирования: Meyer Norbert, Christoph Janine, Makrinioti Heidi, Indermitte Philippe, Rhyner Claudio, Soyka Michael, Eiwegger Thomas, Chalubinski Maciej, Wanke Kerstin, Fujita Hiroyuki, Wawrzyniak Paulina, Bürgler Simone, Zhang Sherrie, Akdis Mübeccel, Menz Günter, Akdis Cezmi. Inhibition of angiogenesis by IL-32: possible role in asthma.. The Journal of allergy and clinical immunology. 2012. DOI: 10.1016/j.jaci.2011.12.1002.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.